WHO ICTRP trial

comparison of pain duration between dexmedtomidine and dexamathasone along with…

CTRI/2024/01/061472 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2024/01/061472
Public title comparison of pain duration between dexmedtomidine and dexamathasone along with ropivacaine in ultrasound guided adductor canal block among patients undergoing unilateral total knee replacement
Scientific title Comparison of Pain Relief Between Dexmedetomidine and Dexamethasone as Adjuvants to Ropivacaine in Ultrasound Guided Adductor Canal Block in Unilateral Total Knee Replacement. - nil
Primary sponsor believers church medical college hospita
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type PMS
Phase Post Marketing Surveillance
Countries India
Conditions Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: E011- Iodine-deficiency related multinodular (endemic) goiter Health Condition 3: E119- Type 2 diabetes mellitus without complications
Interventions Intervention1: ADDUCTOR CANAL BLOCK IN UNILATERAL TKR -DEXMEDETOMIDINE 50MCG, DEXAMETHASONE 4 MG: DEXAMETHASONE 4MG VERSUS DEXMEDETOMIDINE 50MCG AS ADJUVANT TO 0.2% 20ML ROPIVACAINE IN ADDUCTOR CANAL BLOCK IN UNILATERAL TKR Intervention2…
Registration date Jan 15, 2024
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations